CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Beats Revenue Estimates

EarningsPositive
AI Analysis

Summary

Mirum Pharmaceuticals reported Q2 2026 results with a net loss but revenue that exceeded analyst estimates.

Financial Highlights

Revenue

beat estimates

Importance:2/10
Sentiment:
0.30
earningsQ2 2026revenue beat
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 9:25 PM

Read Original